Pharmaceutical product permissions

A searchable record of what Walter is equipped to evaluate.

Explore compositions across oral solids, oral liquids, sterile injectables, topical formats and selected specialist presentations. Use the catalogue to begin a technical and commercial discussion—not as a substitute for written facility-specific confirmation.

5,500Distinct records
21Dosage forms
407Sterile injectable records
17Therapeutic indexes

Built for portfolio teams

Move from a molecule search to a focused feasibility conversation.

The catalogue brings together composition, strength, pharmacological class, dosage form, manufacturing stream, BCS class and documented regulatory references. It also incorporates products listed in Walter’s March 2025 Injectables Manufacturing Profile. Therapeutic and pharmacological classes are practical navigation labels; final indication, regulatory position and site suitability are confirmed product by product.

Search the catalogue

Selected catalogue briefs

Explore a composition for your manufacturing brief.

Browse selected compositions by dosage form, then share the required strength, pack, quantities and target market for a product-specific feasibility review.

Search the full catalogue
Browse 26 selected composition briefs

Therapeutic index

Begin with the treatment area.

Each composition is assigned to one practical primary area for navigation. Combination products may span more than one clinical use and remain subject to product-specific review.

Searchable permissions catalogue

Find a composition, dosage form or capability route.

5,500distinct permission records

Loading full catalogue search…
Therapeutic area
Dosage-form family
Specific dosage form
Pharmacological class
Manufacturing stream
BCS classification
Confirmed CDSCO category
Drugs Rules status

24 records shown

Veterinary productsPRM 2583
Dosage formTablets
Oral

Abamectin 0.00025 g, Praziquantel 0.0065 g

Route
Oral
Formulation type
Solid oral tablet
Pharmacological class
Veterinary antiparasitic + Anthelmintic
Manufacturing stream
Non-beta-lactam
BCS class
Not specified
Regulatory pathwayProduct-specific review

Applicable central and/or state licensing requirements are confirmed against the composition, strength, dosage form and manufacturing unit before commercial commitment.

Veterinary productsPRM 0002
Dosage formBolus
Veterinary oral

Albendazole 3 gm

Route
Veterinary oral
Formulation type
Veterinary oral bolus
Pharmacological class
Anthelmintic
Manufacturing stream
Non-beta-lactam
BCS class
N/A — Other
Drugs Rules status
Schedule HList or category match
Regulatory pathwayProduct-specific review

Applicable central and/or state licensing requirements are confirmed against the composition, strength, dosage form and manufacturing unit before commercial commitment.

Veterinary productsPRM 0003
Dosage formBolus
Veterinary oral

Albendazole 3 gm, Ivermectin 100 mg

Route
Veterinary oral
Formulation type
Veterinary oral bolus
Pharmacological class
Anthelmintic
Manufacturing stream
Non-beta-lactam
BCS class
N/A — Other
Drugs Rules status
Schedule HList or category match
Regulatory pathwayProduct-specific review

Applicable central and/or state licensing requirements are confirmed against the composition, strength, dosage form and manufacturing unit before commercial commitment.

Veterinary productsPRM 2918
Dosage formTablets
Oral

Aziquantal 20 mg, Pyrantel Embonate 230 mg (PR)

Route
Oral
Formulation type
Solid oral tablet
Pharmacological class
Veterinary antiparasitic + Anthelmintic
Manufacturing stream
Non-beta-lactam
BCS class
Not specified
Regulatory pathwayProduct-specific review

Applicable central and/or state licensing requirements are confirmed against the composition, strength, dosage form and manufacturing unit before commercial commitment.

Veterinary productsPRM 0004
Dosage formBolus
Veterinary oral

Ciprofloxacin 1500 mg, Tinidazole 1800 mg

Route
Veterinary oral
Formulation type
Veterinary oral bolus
Pharmacological class
Fluoroquinolone antibiotic
Manufacturing stream
Non-beta-lactam
BCS class
N/A — Other
Drugs Rules status
Schedule HList or category match
Regulatory pathwayProduct-specific review

Applicable central and/or state licensing requirements are confirmed against the composition, strength, dosage form and manufacturing unit before commercial commitment.

Veterinary productsPRM 0005
Dosage formBolus
Veterinary oral

Clomifene Citrate 300 mg, Copper Sulphate 1500 mg

Route
Veterinary oral
Formulation type
Veterinary oral bolus
Pharmacological class
Veterinary therapeutic agent
Manufacturing stream
Non-beta-lactam
BCS class
N/A — Other
Regulatory pathwayProduct-specific review

Applicable central and/or state licensing requirements are confirmed against the composition, strength, dosage form and manufacturing unit before commercial commitment.

Veterinary productsPRM 5478
Dosage formOral suspension
Oral

Cobalt 0.15 mg, Copper 1.25 mg, Levamisole 95.45 mg, Oxyclozanide 150 mg, Zinc 0.4 mg

Route
Oral
Formulation type
Oral liquid suspension
Pharmacological class
Veterinary antiparasitic + Anthelmintic + Mineral supplement
Manufacturing stream
Non-beta-lactam
BCS class
N/A — Oral Liquid
Regulatory pathwayProduct-specific review

Applicable central and/or state licensing requirements are confirmed against the composition, strength, dosage form and manufacturing unit before commercial commitment.

Veterinary productsPRM 3284
Dosage formTablets
Oral

Cobalt 2.25 mg, Copper 18.75 mg, Levamisole 1.27 g, Oxyclozanide 2.0 g, Zinc 6.0 mg

Route
Oral
Formulation type
Solid oral tablet
Pharmacological class
Veterinary antiparasitic + Anthelmintic + Mineral supplement
Manufacturing stream
Non-beta-lactam
BCS class
Not specified
Regulatory pathwayProduct-specific review

Applicable central and/or state licensing requirements are confirmed against the composition, strength, dosage form and manufacturing unit before commercial commitment.

Veterinary productsPRM 5496
Dosage formOral suspension
Oral

Ethixygin 0.125% w/w, Extracted Soya Flour Added To 100%, Parbendazole 4% w/w

Route
Oral
Formulation type
Oral liquid suspension
Pharmacological class
Veterinary antiparasitic
Manufacturing stream
Non-beta-lactam
BCS class
N/A — Oral Liquid
Regulatory pathwayProduct-specific review

Applicable central and/or state licensing requirements are confirmed against the composition, strength, dosage form and manufacturing unit before commercial commitment.

Veterinary productsPRM 5500
Dosage formOral suspension
Oral

Febantel 15 mg, Pyrantel Embonate 14.4 mg / ml

Route
Oral
Formulation type
Oral liquid suspension
Pharmacological class
Veterinary antiparasitic
Manufacturing stream
Non-beta-lactam
BCS class
N/A — Oral Liquid
Regulatory pathwayProduct-specific review

Applicable central and/or state licensing requirements are confirmed against the composition, strength, dosage form and manufacturing unit before commercial commitment.

Veterinary productsPRM 3588
Dosage formTablets
Oral

Febantel 525 mg, Praziquantel 175 mg, Pyrantel 504 mg

Route
Oral
Formulation type
Solid oral tablet
Pharmacological class
Veterinary antiparasitic + Anthelmintic
Manufacturing stream
Non-beta-lactam
BCS class
Class IV (mixed)
Regulatory pathwayProduct-specific review

Applicable central and/or state licensing requirements are confirmed against the composition, strength, dosage form and manufacturing unit before commercial commitment.

Veterinary productsPRM 0006
Dosage formBolus
Veterinary oral

Fenbendazole 150 mg

Route
Veterinary oral
Formulation type
Veterinary oral bolus
Pharmacological class
Veterinary therapeutic agent
Manufacturing stream
Non-beta-lactam
BCS class
N/A — Other
Drugs Rules status
Schedule HList or category match
Regulatory pathwayProduct-specific review

Applicable central and/or state licensing requirements are confirmed against the composition, strength, dosage form and manufacturing unit before commercial commitment.

Veterinary productsPRM 0007
Dosage formBolus
Veterinary oral

Fenbendazole 3 gm, Ivermectin 100 mg

Route
Veterinary oral
Formulation type
Veterinary oral bolus
Pharmacological class
Anthelmintic
Manufacturing stream
Non-beta-lactam
BCS class
N/A — Other
Drugs Rules status
Schedule HList or category match
Regulatory pathwayProduct-specific review

Applicable central and/or state licensing requirements are confirmed against the composition, strength, dosage form and manufacturing unit before commercial commitment.

Veterinary productsPRM 3635
Dosage formTablets
Oral

Fluralaner 1000 mg

Route
Oral
Formulation type
Solid oral tablet
Pharmacological class
Veterinary antiparasitic
Manufacturing stream
Non-beta-lactam
BCS class
Not specified
Regulatory pathwayProduct-specific review

Applicable central and/or state licensing requirements are confirmed against the composition, strength, dosage form and manufacturing unit before commercial commitment.

Veterinary productsPRM 3636
Dosage formTablets
Oral

Fluralaner 112.5 mg

Route
Oral
Formulation type
Solid oral tablet
Pharmacological class
Veterinary antiparasitic
Manufacturing stream
Non-beta-lactam
BCS class
Not specified
Regulatory pathwayProduct-specific review

Applicable central and/or state licensing requirements are confirmed against the composition, strength, dosage form and manufacturing unit before commercial commitment.

Veterinary productsPRM 3637
Dosage formTablets
Oral

Fluralaner 1400 mg

Route
Oral
Formulation type
Solid oral tablet
Pharmacological class
Veterinary antiparasitic
Manufacturing stream
Non-beta-lactam
BCS class
Not specified
Regulatory pathwayProduct-specific review

Applicable central and/or state licensing requirements are confirmed against the composition, strength, dosage form and manufacturing unit before commercial commitment.

Veterinary productsPRM 3638
Dosage formTablets
Oral

Fluralaner 250 mg

Route
Oral
Formulation type
Solid oral tablet
Pharmacological class
Veterinary antiparasitic
Manufacturing stream
Non-beta-lactam
BCS class
Not specified
Regulatory pathwayProduct-specific review

Applicable central and/or state licensing requirements are confirmed against the composition, strength, dosage form and manufacturing unit before commercial commitment.

Veterinary productsPRM 3639
Dosage formTablets
Oral

Fluralaner 500 mg

Route
Oral
Formulation type
Solid oral tablet
Pharmacological class
Veterinary antiparasitic
Manufacturing stream
Non-beta-lactam
BCS class
Not specified
Regulatory pathwayProduct-specific review

Applicable central and/or state licensing requirements are confirmed against the composition, strength, dosage form and manufacturing unit before commercial commitment.

Veterinary productsPRM 5674
Dosage formBolus
Veterinary oral

Furazolidone 500 mg, Loperamide 7.5 mg, Metronidazole 1000 mg

Route
Veterinary oral
Formulation type
Veterinary oral bolus
Pharmacological class
Antidiarrhoeal + Nitrofuran antibacterial + Nitroimidazole antimicrobial
Manufacturing stream
Non-beta-lactam
BCS class
N/A — Other
Regulatory pathwayProduct-specific review

Applicable central and/or state licensing requirements are confirmed against the composition, strength, dosage form and manufacturing unit before commercial commitment.

Veterinary productsPRM 0009
Dosage formBolus
Veterinary oral

Ivermectin 10 mg

Same composition also available as

Liquid injectables

Route
Veterinary oral
Formulation type
Veterinary oral bolus
Pharmacological class
Anthelmintic
Manufacturing stream
Non-beta-lactam
BCS class
N/A — Other
Regulatory pathwayProduct-specific review

Applicable central and/or state licensing requirements are confirmed against the composition, strength, dosage form and manufacturing unit before commercial commitment.

Veterinary productsPRM 5518
Dosage formOral suspension
Oral

Levamisole 1.5%, Oxyclozanide 3.0%

Route
Oral
Formulation type
Oral liquid suspension
Pharmacological class
Veterinary antiparasitic + Anthelmintic
Manufacturing stream
Non-beta-lactam
BCS class
N/A — Oral Liquid
Regulatory pathwayProduct-specific review

Applicable central and/or state licensing requirements are confirmed against the composition, strength, dosage form and manufacturing unit before commercial commitment.

Veterinary productsPRM 0010
Dosage formBolus
Veterinary oral

Levamisole 2 gm, Oxyclozanide 4 gm

Route
Veterinary oral
Formulation type
Veterinary oral bolus
Pharmacological class
Veterinary therapeutic agent
Manufacturing stream
Non-beta-lactam
BCS class
N/A — Other
Drugs Rules status
Schedule HList or category match
Regulatory pathwayProduct-specific review

Applicable central and/or state licensing requirements are confirmed against the composition, strength, dosage form and manufacturing unit before commercial commitment.

Veterinary productsPRM 0011
Dosage formBolus
Veterinary oral

Meloxicam 100 mg, Paracetamol 1500 mg

Route
Veterinary oral
Formulation type
Veterinary oral bolus
Pharmacological class
Analgesic & antipyretic
Manufacturing stream
Non-beta-lactam
BCS class
N/A — Other
Drugs Rules status
Schedule HList or category match
Regulatory pathwayProduct-specific review

Applicable central and/or state licensing requirements are confirmed against the composition, strength, dosage form and manufacturing unit before commercial commitment.

Veterinary productsPRM 4140
Dosage formTablets
Oral

Milbemycin Oxime 12.5 mg, Praziquantel 125 mg

Route
Oral
Formulation type
Solid oral tablet
Pharmacological class
Veterinary antiparasitic + Anthelmintic
Manufacturing stream
Non-beta-lactam
BCS class
Not specified
Regulatory pathwayProduct-specific review

Applicable central and/or state licensing requirements are confirmed against the composition, strength, dosage form and manufacturing unit before commercial commitment.

Explore the product catalogue

Browse product pages by therapeutic area.

Browse compositions, strengths and dosage forms for third-party and contract manufacturing enquiries. Each product page includes its catalogue specification, manufacturing and packaging considerations, and a product-specific enquiry link. Confirm the applicable unit, documents and commercial terms with Walter.

How to read this catalogue

Permission is a starting point—not a supply commitment.

01

Therapeutic index

Primary areas provide buyer-friendly navigation. Combination products may reasonably sit across several clinical categories.

02

Facility confirmation

Current licence scope, site allocation, equipment fit and applicable segregation requirements are checked before commitment.

03

Product feasibility

Formula, strength, presentation, pack, target market, testing requirements and commercial scale are assessed together.

04

Responsible use

This B2B catalogue is not prescribing information, patient guidance or a representation that every composition is currently available for sale.

Start the conversation

Found a composition worth discussing?

Use the enquiry link on any record to carry its composition and dosage form into your manufacturing brief.

Request a quote
Quick chat on WhatsAppLet’s discuss your product